Ethyl 3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-(quinolin-2-ylmethoxy)-1H-indol-2-yl)-2,2-dimethylpropanoate, 98%, 100mg

Dimethylformamide, 99.0%, 1L

Lithium hydroxide monohydrate, min. 56.5% LiOH, 250 g, plastic packaging.

2-Methoxy-n-(2,2,2-trifluoroethyl)aniline, 95%, 5g

(S)-2-(4-(2-Amino-1-methoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-6-yl)piperazin-1-yl)ethan-1-ol, 97%, 50mg

(R)-2-((tert-Butoxycarbonyl)amino)-3-hydroxy-2-methylpropanoic acid, 95.0%, 250mg

7-Methyl-1-tetralone>98.0%(GC)5g

Methyl 5-chlorofuro[2,3-c]pyridine-2-carboxylate, 95%, 500mg

METHYL 3-FLUOROAZETIDINE-3-CARBOXYLATE HCL, 95.0%, 10g

(R)-1-(2-Chloro-6-fluorophenyl)ethanamine hydrochloride, 95.0%, 100mg

Pyrrolo[3,4-d]imidazol-4(1H)-one, 5-(5-chloro-1,2-dihydro-1-methyl-2-oxo-3-pyridinyl)-6-(4-chlorophenyl)-2-(2,4-dimethoxy-5-pyrimidinyl)-5,6-dihydro-1-(1-methylethyl)-, (6S)-, 50mg

1-(2-Methoxyquinolin-3-yl)ethan-1-one, 98%, 5g

6-Bromo-2-(hydroxymethyl)pyridine, 97.0%, 1g